Pine Haven Investment Counsel’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.83M Buy
14,273
+86
+0.6% +$10.1K 1.23% 21
2026
Q1
$1.71M Buy
14,187
+50
+0.4% +$5.77K 1.25% 22
2025
Q4
$1.49M Buy
14,137
+105
+0.7% +$9.86K 1.06% 24
2025
Q3
$1.18M Buy
14,032
+15
+0.1% +$1.24K 0.85% 32
2025
Q2
$1.11M Sell
14,017
-5
-0% -$397 0.87% 33
2025
Q1
$1.26M Sell
14,022
-105
-0.7% -$9.8K 1.06% 27
2024
Q4
$1.41M Buy
14,127
+329
+2% +$33.9K 1.16% 22
2024
Q3
$1.57M Buy
13,798
+46
+0.3% +$5.46K 1.27% 20
2024
Q2
$1.7M Sell
13,752
-40
-0.3% -$5.15K 1.46% 16
2024
Q1
$1.82M Sell
13,792
-50
-0.4% -$6.16K 1.6% 16
2023
Q4
$1.51M Sell
13,842
-10
-0.1% -$1.04K 1.41% 19
2023
Q3
$1.43M Sell
13,852
-55
-0.4% -$5.93K 1.48% 18
2023
Q2
$1.6M Buy
13,907
+105
+0.8% +$11.9K 1.6% 17
2023
Q1
$1.47M Buy
13,802
+68
+0.5% +$7.34K 1.54% 17
2022
Q4
$1.52M Buy
13,734
+350
+3% +$35.8K 1.67% 18
2022
Q3
$1.15M Sell
13,384
-115
-0.9% -$10.3K 1.41% 19
2022
Q2
$1.23M Buy
13,499
+50
+0.4% +$4.43K 1.44% 18
2022
Q1
$1.1M Buy
13,449
+425
+3% +$33.5K 1.08% 25
2021
Q4
$998K Buy
+13,024
New +$1.04M 0.93% 33

Other funds holding MRK

Pine Haven Investment Counsel's MRK Position: Q2 2026 in Review

Pine Haven Investment Counsel increased its Merck (MRK) stake by 0.61% in Q2 2026, buying an estimated $10.1K and bringing the position to 14,273 shares worth $1.83M. The position accounts for 1.23% of the portfolio, ranked #21.

Pine Haven Investment Counsel first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Pine Haven Investment Counsel held 14,273 shares of Merck worth $1.83M as of Q2 2026.
  • Pine Haven Investment Counsel bought 86 Merck shares in Q2 2026, an estimated $10.1K.
  • Merck made up 1.23% of Pine Haven Investment Counsel's portfolio in Q2 2026, its #21 holding.
  • Pine Haven Investment Counsel first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Pine Haven Investment Counsel's 13F filing for Q2 2026, filed 8 Jul 2026.